BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36870679)

  • 1. Posttranslational regulation of liver kinase B1 in human cancer.
    Hu L; Liu M; Tang B; Li Q; Pan BS; Xu C; Lin HK
    J Biol Chem; 2023 Apr; 299(4):104570. PubMed ID: 36870679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling the master-upstream regulation of the tumor suppressor LKB1.
    Kullmann L; Krahn MP
    Oncogene; 2018 Jun; 37(23):3045-3057. PubMed ID: 29540834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
    Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
    Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review).
    Li N; Huang D; Lu N; Luo L
    Oncol Rep; 2015 Dec; 34(6):2821-6. PubMed ID: 26398719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function.
    Gan RY; Li HB
    Int J Mol Sci; 2014 Sep; 15(9):16698-718. PubMed ID: 25244018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
    Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
    Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.
    Corradetti MN; Inoki K; Bardeesy N; DePinho RA; Guan KL
    Genes Dev; 2004 Jul; 18(13):1533-8. PubMed ID: 15231735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.
    Hawley SA; Boudeau J; Reid JL; Mustard KJ; Udd L; Mäkelä TP; Alessi DR; Hardie DG
    J Biol; 2003; 2(4):28. PubMed ID: 14511394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.
    Sapkota GP; Kieloch A; Lizcano JM; Lain S; Arthur JS; Williams MR; Morrice N; Deak M; Alessi DR
    J Biol Chem; 2001 Jun; 276(22):19469-82. PubMed ID: 11297520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LKB1, a protein kinase regulating cell proliferation and polarity.
    Boudeau J; Sapkota G; Alessi DR
    FEBS Lett; 2003 Jul; 546(1):159-65. PubMed ID: 12829253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.
    Collins SP; Reoma JL; Gamm DM; Uhler MD
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):673-80. PubMed ID: 10642527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1-dependent signaling pathways.
    Alessi DR; Sakamoto K; Bayascas JR
    Annu Rev Biochem; 2006; 75():137-63. PubMed ID: 16756488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.
    Jansen M; Ten Klooster JP; Offerhaus GJ; Clevers H
    Physiol Rev; 2009 Jul; 89(3):777-98. PubMed ID: 19584313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
    Lin-Marq N; Borel C; Antonarakis SE
    Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice.
    Hsieh MJ; Weng CC; Lin YC; Wu CC; Chen LT; Cheng KH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LKB1: a sweet side to Peutz-Jeghers syndrome?
    Carling D
    Trends Mol Med; 2006 Apr; 12(4):144-7. PubMed ID: 16530014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
    BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirements for STRAD in LKB1-dependent functions in C. elegans.
    Narbonne P; Hyenne V; Li S; Labbé JC; Roy R
    Development; 2010 Feb; 137(4):661-70. PubMed ID: 20110331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LKB1/Mo25/STRAD uniquely impacts sarcomeric contractile function and posttranslational modification.
    Behunin SM; Lopez-Pier MA; Birch CL; McKee LAK; Danilo C; Khalpey Z; Konhilas JP
    Biophys J; 2015 Mar; 108(6):1484-1494. PubMed ID: 25809261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.